Genomic medicine for kidney disease

EE Groopman, HM Rasouly, AG Gharavi - Nature Reviews Nephrology, 2018 - nature.com
Technologies such as next-generation sequencing and chromosomal microarray have
advanced the understanding of the molecular pathogenesis of a variety of renal disorders …

Genomic medicine for kidney disease

EE Groopman, HM Rasouly… - Nature reviews …, 2018 - pubmed.ncbi.nlm.nih.gov
Technologies such as next-generation sequencing and chromosomal microarray have
advanced the understanding of the molecular pathogenesis of a variety of renal disorders …

[HTML][HTML] Genomic medicine for kidney disease

EE Groopman, HM Rasouly… - Nature reviews …, 2018 - ncbi.nlm.nih.gov
Technologies such as next-generation sequencing and chromosomal microarray have
advanced the understanding of the molecular pathogenesis of a variety of renal disorders …

Genomic medicine for kidney disease.

EE Groopman, HM Rasouly… - Nature reviews …, 2018 - europepmc.org
Technologies such as next-generation sequencing and chromosomal microarray have
advanced the understanding of the molecular pathogenesis of a variety of renal disorders …

[PDF][PDF] Genomic medicine for kidney disease

EE Groopman, HM Rasouly, AG Gharavi - swissdnalysis.ch
Technologies such as next-generation sequencing and chromosomal microarray have
advanced the understanding of the molecular pathogenesis of a variety of renal disorders …

Genomic medicine for kidney disease

EE Groopman, HM Rasouly… - Nature Reviews …, 2018 - search.proquest.com
Technologies such as next-generation sequencing and chromosomal microarray have
advanced the understanding of the molecular pathogenesis of a variety of renal disorders …

Genomic medicine for kidney disease

EE Groopman, HM Rasouly, AG Gharavi - Nature Reviews Nephrology, 2018 - go.gale.com
Although individual inherited kidney diseases are rare, together they account for
approximately 10% of adult end-stage renal disease (ESRD)[1, 2, 3] and at least 70% of …